Martin R. Gaudinski
National Institute of Allergy and Infectious Diseases(US)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, HIV Research and Treatment, Mosquito-borne diseases and control, Monoclonal and Polyclonal Antibodies Research, Viral Infections and Vectors
Most-Cited Works
- → Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates(2020)1,152 cited
- → A proof of concept for structure-based vaccine design targeting RSV in humans(2019)327 cited
- → Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials(2017)300 cited
- → Safety and pharmacokinetics of the Fc-modified HIV-1 human monoclonal antibody VRC01LS: A Phase 1 open-label clinical trial in healthy adults(2018)251 cited
- → Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants(2021)213 cited
- → Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trial(2022)157 cited
- → Booster of mRNA-1273 Strengthens SARS-CoV-2 Omicron Neutralization(2021)129 cited
- → Safety, tolerability, pharmacokinetics, and immunogenicity of the therapeutic monoclonal antibody mAb114 targeting Ebola virus glycoprotein (VRC 608): an open-label phase 1 study(2019)125 cited
- → Safety and Efficacy of a Monoclonal Antibody against Malaria in Mali(2022)118 cited
- → Low-Dose Subcutaneous or Intravenous Monoclonal Antibody to Prevent Malaria(2022)115 cited